Zhi Zhang
Nanjing, 210000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Prevalence and therapeutic response of EGFR T790I mutation in NSCLC patients with acquired resistance to EGFR-TKIs: a retrospective cohort study.
Journal: BMC cancer
Published: June 27, 2025
Efficacy and safety of concurrent chemoradiotherapy with paclitaxel-based or S-1 regimens in treating elderly patients with esophageal squamous cell carcinoma: A multi-center propensity-score matched study.
Journal: Translational oncology
Published: June 04, 2024
Efficacy, safety, and survival of neoadjuvant immunotherapy plus chemotherapy in locally advanced esophageal squamous cell carcinoma: A real-world retrospective study.
Journal: International immunopharmacology
Published: March 17, 2024
A Multicenter Study on Mortality and Risk Factors in Patients with Acute Exacerbation of Cor Pulmonale in Plateau of China from 2012 to 2022.
Journal: Journal of epidemiology and global health
Published: February 07, 2024
Clinical Efficacy of Taxol Plus Platinum (TP) Chemotherapy Combined with Delayed Administration of PD-1 Inhibitors in Patients with Locally Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma: A Retrospective Study.
Journal: Drug design, development and therapy
Published: February 03, 2024
Radiotherapy with S-1 for the treatment of esophageal squamous cell carcinoma 75 years or older.
Journal: Radiation oncology (London, England)
Published: January 21, 2024
Comparison of immunochemotherapy followed by surgery or chemoradiotherapy in locally advanced esophageal squamous cell cancer.
Journal: International immunopharmacology
Published: December 25, 2023
Induction sintilimab and chemotherapy followed by concurrent chemoradiotherapy for locally advanced esophageal cancer: a proof-of-concept, single-arm, multicenter, phase 2 trial.
Journal: EClinicalMedicine
Published: September 26, 2023
Impact of hematological and radiation parameters on the clinical prognosis of esophageal cancer patients treated with definitive chemoradiotherapy.
Journal: American journal of cancer research
Published: May 21, 2023
Novel considerations on EGFR-based therapy as a contributor to cancer cell death in NSCLC.
Journal: Frontiers in oncology
Published: December 09, 2022
Last Updated: 09/26/2026